Iron therapy and severe arrhythmias in HFrEF: rationale, study design, and baseline results of the RESAFE‐HF trial

Iron therapy and severe arrhythmias in HFrEF: rationale, study design, and baseline results of the RESAFE‐HF trial

Abstract Aims The Iron Intravenous Therapy in Reducing the burden of Severe Arrhythmias in HFrEF (RESAFE‐HF) registry study aims to provide real‐word evidence on the impact of intravenous ferric carboxymaltose (FCM) on the arrhythmic burden of patients with heart failure with reduced ejection fracti...

Full description

Bibliographic Details
Main Authors: Constantinos Bakogiannis, Dimitrios Mouselimis, Anastasios Tsarouchas, Christodoulos E. Papadopoulos, Efstratios K. Theofillogiannakos, Elmira Lechat, Antonios P. Antoniadis, Efstathios D. Pagourelias, Ioannis Kelemanis, Stergios Tzikas, Nikolaos Fragakis, Georgios K. Efthimiadis, Theodoros D. Karamitsos, Michael Doumas, Vassilios P. Vassilikos
Format: Article
Language:English
Published: Wiley 2023-04-01
Series:ESC Heart Failure
Subjects:
Heart failure
HFrEF
Iron deficiency
Arrhythmia
Ferric carboxymaltose
FCM
Online Access:https://doi.org/10.1002/ehf2.14276

Internet

https://doi.org/10.1002/ehf2.14276

Similar Items